In individuals with hepatic harm, barbiturates should be administered with warning and at first in decreased doses. Barbiturates really should not be administered to patients demonstrating the premonitory indications of hepatic coma.Secobarbital is really a member of the barbiturate class of medications. Numerous drugs On this class induce CYP2C19